Ubs Asset Management Americas Inc Amneal Pharmaceuticals, Inc. Transaction History
Ubs Asset Management Americas Inc
- $417 Billion
- Q4 2024
A detailed history of Ubs Asset Management Americas Inc transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 318,420 shares of AMRX stock, worth $2.86 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
318,420
Previous 218,554
45.69%
Holding current value
$2.86 Million
Previous $1.82 Million
38.67%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding AMRX
# of Institutions
205Shares Held
124MCall Options Held
362KPut Options Held
141K-
Vanguard Group Inc Valley Forge, PA14.8MShares$133 Million0.0% of portfolio
-
Tpg Gp A, LLC Fort Worth, TX12.3MShares$111 Million2.69% of portfolio
-
Black Rock Inc. New York, NY11.3MShares$101 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY10.7MShares$96.2 Million1.4% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il8.98MShares$80.6 Million0.01% of portfolio
About Amneal Pharmaceuticals, Inc.
- Ticker AMRX
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 151,408,992
- Market Cap $1.36B
- Description
- Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...